The Unfinished Science of Boxed Drug Warnings

• by John G. Rizk, John C. Lewin

• May 22, 2026

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

• by Kathryn Wighton

• May 29, 2026

• 3 min

Melatonin suppresses ILC2-driven airway hyperreactivity via glutathione-dependent metabolic reprogramming

• by Jafar Cain, Benjamin P. Hurrell, Stephen Shen, Paul Speliakos, Omid Akbari

• May 11, 2026

A dynamic vascular–inflammatory–fibrotic loop in systemic sclerosis: an integrative immuno-vascular framework

• by Razvan Constantin Ionitescu

• May 1, 2026